Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
In recent years Guo Chao has been rising Concepts such as madeinChina crossover cobranding and IP have become hot topics in todays society The rise of Guo Chao has also brought vitality and new opportunities for the packaging industry The Baidu Guo C...
Spero Therapeutics Inc a multiasset clinicalstage biopharmaceutical company focused on identifying developing and commercializing treatments in high unmet need areas involving multidrug resistant bacterial infections and rare diseases today announc...
Allogene Therapeutics Inc a clinicalstage biotechnology company pioneering the development of allogeneic CAR T AlloCAR T therapies for cancer today announced that the US Food and Drug Administration FDA has granted Fast Track designation to ALLO the...
Jazz Pharmaceuticals plc today announced the US Food and Drug Administration FDA approval of Rylaze asparaginase erwinia chrysanthemi recombinantrywn for use as a component of a multiagent chemotherapeutic regimen for the treatment of acute lymphobla...
Connecting the whole pharmaceutical value chain and focusing on manufacturing and packaging sides of the industry were the main directions of the Pharmaceutical Manufacturing and Packaging Congress PHARMAP It took place on the BGS online platform o...
Antibody therapies have become an integral part of treating serious and rare diseases It is all the more important that we have a high level of expertise in drug development as well as in bioprocess development and production of therapeutic antibodie...
Lonza today announced new investments in GMP laboratories and midscale manufacturing assets at its API manufacturing center in Nansha China The investments totaling over CHF million will allow Lonza to provide a smoother transition from smallscale t...
Roche announced today that the European Commission EC has approved ENSPRYNG satralizumab for the treatment of adults and adolescents from years of age living with antiaquaporin antibody AQPIgG seropositive neuromyelitis optica spectrum disorder NMOS...
Innovent Biologics Inc a worldclass biopharmaceutical company that develops manufactures and commercializes highquality medicines for the treatment of cancer metabolic autoimmune and other major diseases announced the signing of a nonexclusive target...
Asklepios BioPharmaceutical Inc AskBio a wholly owned and independently operated subsidiary of Bayer AG announced that the US Food Drug Administration FDA has granted Fast Track Designation for the LION gene therapy program LION is a novel recombina...
